Markets US Stocks Health Technology Biotechnology BCRX Financials

BioCryst Pharmaceuticals, Inc

BCRX

See more on advanced chart See more on advanced chart

No trades

See more on advanced chart See more on advanced chart

Overview News Ideas

Financials

BCRX financial statements

The current financial position of BioCryst Pharmaceuticals, Inc

Total assets of BCRX for Q1 22 is 527.72M USD, 10.27% less than the previous Q4 21. And total liabilities decreased by 0.46% in Q1 22 to 691.93M USD.

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—